Tymoczko J L, Phillips M M
Endocrinology. 1983 Jan;112(1):142-9. doi: 10.1210/endo-112-1-142.
The ability of the dexamethasone (9 alpha-fluoro-11 beta, 17,21-trihydroxy-16 alpha-methylpregna-1,4-diene-3,20-dione)-receptor complex to bind to DNA-cellulose is stimulated by RNase treatment of the activated receptor. Both RNase A and RNase T1 can induce the stimulation. The enhancement of the DNA binding ability occurs concomitantly with an alteration of the sedimentation profile of the dexamethasone-receptor complex from the 7-8S form to the 3-4S form in low salt sucrose gradients. If RNase treatment occurs in the presence of sodium molybdate, both the increase in DNA binding ability and the alteration in sedimentation profile fail to occur. Treatment of the receptor with high salt suggests that the 3-4S form can reversibly combine with a factor in a salt-sensitive association. These experiments indicate that the 7-8S form of the dexamethasone-receptor complex is associated with a RNA molecule(s) that can be removed by RNase treatment or salt dissociation, and that this RNA inhibits the binding of the receptor to DNA.
地塞米松(9α-氟-11β,17,21-三羟基-16α-甲基孕甾-1,4-二烯-3,20-二酮)-受体复合物与DNA纤维素结合的能力,可通过对活化受体进行核糖核酸酶处理来增强。核糖核酸酶A和核糖核酸酶T1均可诱导这种增强作用。在低盐蔗糖梯度中,DNA结合能力的增强与地塞米松-受体复合物沉降图谱从7-8S形式转变为3-4S形式同时发生。如果在钼酸钠存在的情况下进行核糖核酸酶处理,则DNA结合能力的增加和沉降图谱的改变均不会发生。用高盐处理受体表明,3-4S形式可与一种对盐敏感的因子可逆结合。这些实验表明,地塞米松-受体复合物的7-8S形式与一个或多个RNA分子相关联,这些RNA分子可通过核糖核酸酶处理或盐解离去除,并且这种RNA会抑制受体与DNA的结合。